Clients who are unable to wander because of paralysis, but who will be up in the wheelchair, will probably be regarded as ambulatory for the goal of evaluating the overall performance rating Experimental: Dose expansion_sub-population 2_higher dose of niraparib MTDs and/or candidate RP2Ds for elimusertib utilised together with niraparib at https://rosthornina88765.blogdigy.com/getting-my-molnupiravir-to-work-40538022